2024 年至 2032 年即时血糖测试市场机会、成长动力、产业趋势分析与预测

Point-of-Care Glucose Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: 2024年09月03日 | 出版商:

Global Market Insights Inc. | 英文 85 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球即时血糖测试市场价值为 34 亿美元，预计 2024 年至 2032 年复合年增长率为 4.7%。管理。与连续血糖监测系统和先进感测器技术整合等创新正在改变血糖水平监测和管理。 2023 年 2 月，Dexcom 推出了新一代 Dexcom G7 CGM 系统，其感测器比其前身 G6 小 60%。 G7 直接向智慧型手机或智慧手錶提供即时血糖资料，无需进行指尖采血测试。它专为患有 1 型、2 型或妊娠糖尿病的个体而设计。

许多即时血糖仪现在都具有蓝牙或 Wi-Fi 功能，可将资料无缝传输到智慧型手机、平板电脑或云端平台。这增强了资料管理并支援医疗保健专业人员进行远端监控。 Abbott 的 FreeStyle Libre 3 透过紧凑型感测器提供即时血糖读数，并与 FreeStyle LibreLink 应用程式整合以进行连续追踪和资料共享。市场依产品类型分为采血装置、测试条及血糖仪。

预计到 2032 年，试纸市场将达到 23 亿美元。测试条的使用者友善设计只需最少的培训，使患者和医疗保健提供者都可以使用它们。该过程包括将少量血液样本放在试纸上并将其插入血糖仪中，以方便使用。市场依最终用途分为医院、诊所、诊断中心、家庭护理机构和其他最终用户。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	34亿美元
预测值	51 亿美元
复合年增长率	4.7%

到 2023 年，家庭护理环境细分市场将达到 13 亿美元。它们让糖尿病患者在家中方便地管理自己的病情，减少经常去医疗机构就诊的需要。预计从 2024 年到 2032 年，英国的即时血糖检测市场将显着成长。国家医疗服务体系 (NHS) 为整合新医疗技术提供了全面的框架，包括即时照护 (POC) 血糖检测系统。许多大学和研究机构专注于推进诊断技术，包括血糖监测。这项研究有助于开发更准确、更有效率且用户友好的即时血糖测试设备。

产业生态系统分析
产业影响力
- 成长动力
  - 糖尿病盛行率增加
  - 血糖监测技术进步
  - 老年人口不断增加
  - 连续血糖监测仪的采用越来越多
- 产业陷阱与挑战
  - 先进设备成本高
  - 严格的监管挑战
成长潜力分析
技术景观
监管环境
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032

主要趋势
采血装置
试纸条
血糖仪

第 6 章：市场估计与预测：按最终用途分类，2021 - 2032 年

主要趋势
医院
诊所
诊断中心
家庭护理设置
其他最终用户

第 7 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Abbott Laboratories
ARKRAY, Inc.
ACON Laboratories, Inc.
B. Braun Melsungen AG
Dexcom, Inc.
EKF Diagnostics Holdings plc
F. Hoffmann-La Roche Ltd.
Medtronic plc
Nipro Corporation
Nova Biomedical Corporation
PHC Holdings
Prodigy Diabetes Care, LLC.
Platinum Equity Advisors, LLC.
Sanofi
Sinocare

简介目录

Product Code: 11241

The Global Point-of-Care Glucose Testing Market was valued at USD 3.4 billion in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to 2032. Recent advancements in point-of-care (POC) glucose testing have significantly improved the accuracy, convenience, and management of diabetes. Innovations such as integration with continuous glucose monitoring systems and advanced sensor technologies are transforming glucose level monitoring and management. In February 2023, Dexcom launched its next-generation Dexcom G7 CGM System, featuring a sensor 60% smaller than its predecessor, the G6. The G7 provides real-time glucose data directly to smartphones or smartwatches, eliminating the need for fingerstick tests. It is designed for individuals with type 1, type 2, or gestational diabetes.

Many point-of-care glucose meters now include Bluetooth or Wi-Fi capabilities for seamless data transfer to smartphones, tablets, or cloud platforms. This enhances data management and enables remote monitoring by healthcare professionals. Abbott's FreeStyle Libre 3 offers real-time glucose readings through a compact sensor and integrates with the FreeStyle LibreLink app for continuous tracking and data sharing. The market is segmented by product type into lancing devices, test strips, and blood-glucose meters.

The test strips segment is forecasted to reach USD 2.3 billion by 2032. Test strips offer high accuracy and precision in glucose measurement, which is essential for effective diabetes management. The user-friendly design of test strips requires minimal training, making them accessible for both patients and healthcare providers. The process involves placing a small blood sample on the strip and inserting it into a glucose meter, facilitating ease of use. The market is bifurcated by end-use into hospitals, clinics, diagnostic centers, home care settings, and other end-users.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$3.4 Billion
Forecast Value	$5.1 Billion
CAGR	4.7%

The home care settings segment accounted for USD 1.3 billion in 2023. Home care settings offer significant advantages for point-of-care glucose testing. They allow individuals with diabetes to manage their condition conveniently from home, reducing the need for frequent healthcare facility visits. The point-of-care glucose testing market in the UK is expected to experience significant growth from 2024 to 2032. The UK benefits from a well-established and sophisticated healthcare infrastructure. The National Health Service (NHS) provides a comprehensive framework for the integration of new medical technologies, including point-of-care (POC) glucose testing systems.The UK is a hub for medical research and innovation. Numerous universities and research institutions focus on advancing diagnostic technologies, including glucose monitoring. This research contributes to the development of more accurate, efficient, and user-friendly point-of-care glucose testing devices.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of diabetes
  - 3.2.1.2 Technological advancements in glucose monitoring
  - 3.2.1.3 Rising geriatric population
  - 3.2.1.4 Growing adoption of continuous glucose monitors
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of advanced devices
  - 3.2.2.2 Stringent regulatory challenges
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Lancing devices
5.3 Test strips
5.4 Blood-glucose meter

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospitals
6.3 Clinics
6.4 Diagnostic centers
6.5 Home care settings
6.6 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa